FDA Approves Roche’s Wilserdly for Advanced Breast Cancer After Hormone Therapy Fails
The once-daily pill, taken with everolimus, nearly doubled the time before the disease worsened in patients whose tumours carry an ESR1 mutation.
The once-daily pill, taken with everolimus, nearly doubled the time before the disease worsened in patients whose tumours carry an ESR1 mutation.